Archives for January 13, 2010

← 2010

Pall buys MRT for mini MTPD technology

By Gareth Macdonald

Pall says its acquisition of MicroReactor Technologies (MRT) broadens its offering in the $1bn (€689m) a year global biopharmaceutical process development market.

Genzyme’s preliminary revenues dip

By Nick Taylor

Genzyme has reported a small dip in preliminary fourth quarter and full year revenues, driven by declining sales of Cerezyme and Fabrazyme which have been affected by manufacturing problems.

Deals and developments in the CRO sector

By Staff Reporter

Outsourcing-pharma presents a round up of all the latest deals and developments in the contract research space. This week Synexus closes ClinPharm deal, GVK joins ResearchPoint Global and CliniPace wins gNO contract.

Cel-Sci validates manufacturing facility

By Nick Taylor

Cel-Sci has completed validation of critical utilities and production equipment at its GMP facility which uses cold 4ºC aseptic filling to improve the shelf-life and potency and biologics.

Novavax scales up RSV-F vaccine

By Nick Taylor

Novavax has completed cGMP scale up of its RSV-F vaccine candidate, with the material being used in preclinical studies, and amended the terms of the H1N1 collaboration with Xcellerex.